Use of Wnt5-α peptide derivates for the treatment of melanoma and gastric cancer
US8497352B2 · kind B2 · utility
3Cited by
3References
15Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 13, 2009 |
| Grant date | Jul 30, 2013 |
| Priority date | — |
| Expiry date | Aug 13, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel unbranched carbamate derivative, in particular N-butyloxycarbonyl derivative of certain Wnt5-α peptides and to their use in the treatment of melanoma or gastric cancer, as well as a method for treating melanoma as well as a pharmaceutical composition comprising the same derivative.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.